Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | AMG 119 |
Trade Name | |
Synonyms | AMG-119|AMG119 |
Drug Descriptions |
AMG 119 are autologous T-cells that have been engineered to express a chimeric antigen receptor (CAR) that targets DLL3, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (J of Thoracic Oncology. 2018, 13(Supplement), S971. P3.12-03). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C150586 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AMG 119 | AMG 119 | 0 | 0 |